Search research articles
Contact Us
Filters
Showing results (11-20 of 75) with videos related to
Page
of 8
Sort By:
Current Medical Research and Opinion
|
April 10, 2008
Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia
Douglas E Faries, Haya Ascher-Svanum, Allen W Nyhuis, et al.
Journal of Medical Economics
|
February 22, 2013
Longitudinal analysis of healthcare costs: a case study of patients with major depressive disorder treated with duloxetine
Zhanglin Cui, Douglas E Faries, Wei Shen, et al.
BMC Psychiatry
|
September 4, 2009
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
Douglas E Faries, Haya Ascher-Svanum, Allen W Nyhuis, et al.
BMC Family Practice
|
October 17, 2012
A cross-validation of the provisional diagnostic instrument (PDI-4)
Douglas E Faries, John P Houston, Ellen M Sulcs, et al.
Clinical Therapeutics
|
October 25, 2011
Dosing patterns for duloxetine and predictors of high-dose prescriptions in patients with major depressive disorder: analysis from a United States third-party payer perspective
Xianchen Liu, Zhanglin Cui, Liyuan Niu, et al.
BMC Research Notes
|
January 14, 2009
Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia
Haya Ascher-Svanum, Baojin Zhu, Douglas E Faries, et al.
Journal of Biopharmaceutical Statistics
|
April 22, 2025
Double machine learning methods for estimating average treatment effects: a comparative study
Xiaoqing Tan, Shu Yang, Wenyu Ye, et al.
Pharmacoepidemiology and Drug Safety
|
July 12, 2016
"A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis"
Xiang Zhang, Douglas E Faries, Natalie Boytsov, et al.
Pharmacoepidemiology and Drug Safety
|
February 1, 2018
Addressing unmeasured confounding in comparative observational research
Xiang Zhang, Douglas E Faries, Hu Li, et al.
BMC Psychiatry
|
August 30, 2011
Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study
Gebra B Cuyún Carter, Denái R Milton, Haya Ascher-Svanum, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 75) with videos related to
Sort By:
Page
of 8
Current Medical Research and Opinion
|
April 10, 2008
Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia
Douglas E Faries, Haya Ascher-Svanum, Allen W Nyhuis, et al.
Journal of Medical Economics
|
February 22, 2013
Longitudinal analysis of healthcare costs: a case study of patients with major depressive disorder treated with duloxetine
Zhanglin Cui, Douglas E Faries, Wei Shen, et al.
BMC Psychiatry
|
September 4, 2009
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
Douglas E Faries, Haya Ascher-Svanum, Allen W Nyhuis, et al.
BMC Family Practice
|
October 17, 2012
A cross-validation of the provisional diagnostic instrument (PDI-4)
Douglas E Faries, John P Houston, Ellen M Sulcs, et al.
Clinical Therapeutics
|
October 25, 2011
Dosing patterns for duloxetine and predictors of high-dose prescriptions in patients with major depressive disorder: analysis from a United States third-party payer perspective
Xianchen Liu, Zhanglin Cui, Liyuan Niu, et al.
BMC Research Notes
|
January 14, 2009
Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia
Haya Ascher-Svanum, Baojin Zhu, Douglas E Faries, et al.
Journal of Biopharmaceutical Statistics
|
April 22, 2025
Double machine learning methods for estimating average treatment effects: a comparative study
Xiaoqing Tan, Shu Yang, Wenyu Ye, et al.
Pharmacoepidemiology and Drug Safety
|
July 12, 2016
"A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis"
Xiang Zhang, Douglas E Faries, Natalie Boytsov, et al.
Pharmacoepidemiology and Drug Safety
|
February 1, 2018
Addressing unmeasured confounding in comparative observational research
Xiang Zhang, Douglas E Faries, Hu Li, et al.
BMC Psychiatry
|
August 30, 2011
Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study
Gebra B Cuyún Carter, Denái R Milton, Haya Ascher-Svanum, et al.
Page
of 8